Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
7.04
-0.62
(-8.09%)
At close: March 10 at 4:00:02 PM EDT
7.25
+0.21
+(2.98%)
After hours: March 10 at 7:11:08 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-154,648
-86,483
-109,722
-100,086
Investing Cash Flow
163,506
-127,564
193,710
-67,031
Financing Cash Flow
-37,977
124,248
6,319
174,534
End Cash Position
1,521
11,009
100,808
10,501
Interest Paid Supplemental Data
34,244
19,178
17,876
11,603
Capital Expenditure
-257
-113
-277
-283
Issuance of Capital Stock
--
--
--
93,675
Issuance of Debt
--
--
--
225,030
Repayment of Debt
-122,778
-1,167
-1,823
-126,833
Repurchase of Capital Stock
-16,505
--
--
--
Free Cash Flow
-154,905
-86,596
-109,999
-100,369
12/31/2020 - 10/8/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OCUL Ocular Therapeutix, Inc.
7.65
+1.46%
ACAD ACADIA Pharmaceuticals Inc.
17.19
-2.11%
SGMO Sangamo Therapeutics, Inc.
0.9886
-4.94%
CRDF Cardiff Oncology, Inc.
3.8400
-0.39%
IONS Ionis Pharmaceuticals, Inc.
32.22
-4.70%
KRYS Krystal Biotech, Inc.
183.75
+2.12%
SNDX Syndax Pharmaceuticals, Inc.
12.53
-6.63%
RGLS Regulus Therapeutics Inc.
1.3300
+3.10%
ALDX Aldeyra Therapeutics, Inc.
6.62
+4.25%
INCY Incyte Corporation
71.13
+0.48%